| Literature DB >> 28797588 |
Marika Pane1, Leonardo Lapenta1, Emanuela Abiusi2, Roberto de Sanctis3, Marco Luigetti4, Concetta Palermo3, Domiziana Ranalli1, Stefania Fiori2, Francesco Danilo Tiziano2, Eugenio Mercuri5.
Abstract
We report longitudinal clinical and neurophysiological assessments in twins affected by spinal muscular atrophy (SMA) with discordant phenotypes. The boy had the homozygous deletion of SMN1, a typical type 1 SMA course, and died at the age of eight months. His twin sister, asymptomatic at the time of the diagnosis in her brother, had the same genetic defect but she developed clinical and electrophysiological signs of type 2 SMA. The reduction of tendon reflexes was the first clinical sign at the age of 4 months, followed within few weeks, by a mild decrement in the amplitude of the compound motor action potentials. After the age of 9 months, she showed a sudden clinical and electrophysiological deterioration. Among molecular tests, we determined SMN2 copy number, SMN2 and Plastin 3 transcript levels in peripheral blood, and observed no relevant differences between twins.Entities:
Keywords: CMAP; Modifiers; Phenotypes; Spinal muscular atrophy; Twins
Mesh:
Substances:
Year: 2017 PMID: 28797588 DOI: 10.1016/j.nmd.2017.06.559
Source DB: PubMed Journal: Neuromuscul Disord ISSN: 0960-8966 Impact factor: 4.296